The BioCryst Pharmaceuticals Inc. (BCRX) Given Buy Rating at the FBR & Co

The brokerage currently has a $6.00 price target on the biotechnology company’s stock. BCRX has been the subject of a number of other reports.

Advertisements
The BioCryst Pharmaceuticals Inc. (BCRX) Given Buy Rating at the FBR & Co

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s